Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Biotech
Undaunted Vertex closes in on FDA nod for non-opioid pain drug
While other companies gave up on trying to develop a non-opioid pain relief medicine by targeting sodium channel inhibition, Vertex stayed the course.
Kevin Dunleavy
Oct 28, 2024 5:00am
Rectify drug repairs bile composition in mice with liver disease
Oct 22, 2024 7:00am
Vertex pain data: Combo results, Vicodin miss and stellar safety
Oct 21, 2024 9:55am
Editas cashes in on Vertex Cas9 licensing agreement for $57M
Oct 4, 2024 5:06am
Vertex, beaten by AATD again, drops 2 assets on discard pile
Aug 2, 2024 5:39am
Vertex mines for more gene editing riches with $15M Orum deal
Jul 16, 2024 7:00am